Congress has consistently approved blocks on human gene editing technology – demonstrating their support for a ban.
Walter G. Johnson and Diana M. Bowman April 22, 2022 It’s time for Congress to stop blocking mitochondrial replacement therapy https://www.statnews.com/2022/04/22/congress-allow-mitochondrial-replacement-more-forward/
Lawmakers have done this by including a rider in laws that fund the FDA each year. These say that the FDA cannot use any of its funding to review an application to start clinical trials on “a drug or biological product … in research in which a human embryo is intentionally created or modified to include a heritable genetic modification.” The rider was in 2015, but there was no public discussion at the time about the effects the rider would have on mitochondrial replacement. While the rider was likely originally intended to block gene editing of the nuclear DNA with tools like CRISPR, the the ban to apply to mitochondrial replacement as well, even though no nuclear DNA is edited.